Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 147.50 GBp
Change Today -2.50 / -1.67%
Volume 35.6K
AMS On Other Exchanges
As of 8:07 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

advanced medical solutions (AMS) Snapshot

150.00 GBp
Previous Close
150.00 GBp
Day High
150.00 GBp
Day Low
147.25 GBp
52 Week High
05/21/15 - 161.00 GBp
52 Week Low
11/6/14 - 111.00 GBp
Market Cap
Average Volume 10 Days
0.06 GBp
Shares Outstanding
0.78 GBp
Dividend Yield

Related News

No related news articles were found.

advanced medical solutions (AMS) Related Businessweek News

No Related Businessweek News Found

advanced medical solutions (AMS) Details

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes natural and synthetic polymers for use in advanced woundcare products and surgical dressings worldwide. The company operates through Branded Direct, Branded Distributed, Original Equipment Manufacturer, and Bulk Materials segments. It also offers medical adhesives and sutures for closing and sealing tissues; haemostats; and bulk materials to medical device partners and convertors. The company offers its advanced woundcare products under the ActivHeal brand name; medical adhesives under the LiquiBand brand; and sutures and haemostats under the RESORBA brand name. It serves healthcare companies and distributors, as well as hospital and dental markets, and NHS. The company was founded in 1991 and is headquartered in Winsford, the United Kingdom.

470 Employees
Last Reported Date: 04/21/15
Founded in 1991

advanced medical solutions (AMS) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: 386.0K GBP
Group Finance Director, Company Secretary and...
Total Annual Compensation: 256.0K GBP
Compensation as of Fiscal Year 2014.

advanced medical solutions (AMS) Key Developments

Advanced Medical Solutions Group plc Reaffirms Revenue Outlook for the First Half and Provides Earnings Outlook for the Year 2015

Advanced Medical Solutions Group plc reaffirmed revenue outlook for the first half and provided earnings outlook for the year 2015. For the six months, the company confirmed that trading is in line with the Board's expectations. For the year 2015, the company expects both revenue and profitability to be in line with present market expectations.

Advanced Medical Solutions Group plc - Analyst/Investor Day

To provide corporate update on strategy and to focus on the US market and LiquiBand®, a surgeon discussion on the benefits of LiquiBand® Fix 8™, and a session on innovation and market opportunities across the complete AMS product platform

Advanced Medical Solutions Group plc Proposes Final Dividend, Payable on May 29, 2015; Reports Unaudited Consolidated Earnings Results for the Year Ended December 31, 2014

Advanced Medical Solutions Group plc announced that the Board has proposed a final dividend of 0.48 pence per share, making a total dividend for the year of 0.70 pence per share, a 16.7% increase on 2014. If approved at the Annual General Meeting on May 21, 2015, this will be paid on May 29, 2015 to shareholders on the register at the close of business on May 8, 2015. The company reported unaudited consolidated earnings results for the year ended December 31, 2014. For the period, the company reported revenue from continuing operations of GBP 63,010,000 compared to GBP 59,499,000 a year ago. Profit from operations was GBP 15,170,000 compared to GBP 13,726,000 a year ago. Profit before taxation was GBP 15,218,000 compared to GBP 13,144,000 a year ago. Profit attributable to equity holders of the parent was GBP 12,864,000 compared to GBP 11,366,000 a year ago. Diluted earnings per share were 6.08 pence compared to 5.45 pence a year ago. Adjusted diluted earnings per share were 6.26 pence compared to 5.64 pence a year ago. Net cash inflow from operating activities was GBP 16,572,000 compared to GBP 14,070,000 a year ago. Purchase of software was GBP 408,000 compared to GBP 618,000 a year ago. Purchases of property, plant and equipment was GBP 1,478,000 compared to GBP 836,000 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMS:LN 147.50 GBp -2.50

AMS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AMS.
View Industry Companies

Industry Analysis


Industry Average

Valuation AMS Industry Range
Price/Earnings 24.4x
Price/Sales 4.9x
Price/Book 3.3x
Price/Cash Flow 24.0x
TEV/Sales 4.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVANCED MEDICAL SOLUTIONS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at